S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|Pacira Pharmaceuticals, Inc. Reports Third Quarter EXPAREL Revenue of $50.2 Million and Third Quarter 2014 Results|
|Pacira Pharmaceuticals, Inc. to Present at the Jefferies 2014 Global London Healthcare Conference|
|Pacira Pharmaceuticals Shareholder Alert: Former SEC Attorney Willie Briscoe and Powers Taylor Investigate Possible Breaches of Fiduciary Duty by Officers and Directors (2014/11/18)|
|Pacira Pharmaceuticals, Inc. to Present at the 26th Annual Piper Jaffray Healthcare Conference|
|Pacira Pharmaceuticals, Inc. to Host Analyst & Investor Day on Jan. 22 in New York|
|DEADLINE ALERT: Rigrodsky & Long, P.A. Reminds Shareholders Of Pacira Pharmaceuticals, Inc. Of Upcoming Deadline (2014/11/17)|
|Pacira Pharmaceuticals, Inc. Reports Estimated Fourth Quarter Total Revenue of $61.8 Million and Estimated Full-Year Total Revenue of $197.7 Million|
|Pacira Pharmaceuticals Inc. Announces Changes to EXPAREL® Label|
|Pacira Pharmaceuticals Inc. Announces New Data on the Use of EXPAREL to Treat Postsurgical Pain Following Total Knee Arthroplasty|
|EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Against Pacira Pharmaceuticals, Inc. -- PCRX|
Click above to view more mutual fund data and stats for pcrx - Pacira Pharmaceuticals Inc.